UNSPSC 51386005: Cliprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H11ClO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BB27ZR25WO, chemically known as benzeneacetic acid, 3-chloro-alpha-methyl-4-(2-thienylcarbonyl)- but generally known as cliprofen, which bears US NIH Compound Identifier 167449. European Medicines Agency schedules Cliprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06671MIG.

UNSPSC 51386005 Cliprofen is a Commodity code that in practice captures pharmaceutical procurement by state and local health agencies, though the single recent opportunity on record shows a mismatch between the code's nominal scope and the work actually being tagged under it. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually — neither of which is Cliprofen. The solicitation calls for quarterly deliveries to the Seminole County Community Health Building in Sanford, with vendors responsible for all shipping costs, electronic bid submission through the county's e-Procurement Portal, and compliance with drug-free workplace certification, E-Verify requirements, workers' compensation and commercial general liability insurance, and a three-month probationary termination period. The contract carries a two-year initial term with an option for one-year renewal and is potentially funded through FEMA, introducing federal compliance requirements under the Clean Air Act and Federal Water Pollution Control Act.

The code shows limited recent activity relevant to its stated scope; the single posted opportunity addresses opioid reversal and controlled-substance destruction rather than ibuprofen-related pharmaceuticals. The issuing body is a county health department in Florida, and the response deadline for the Naloxone and drug deactivation solicitation was July 26, 2023 — a date that predates the current posting date of June 2026. This temporal inconsistency and the categorical mismatch between Cliprofen and Naloxone suggest either a data error in the underlying source or a coding anomaly in how this opportunity was tagged. Practitioners should verify whether activity under this code is substantive or whether the code is rarely used for state and local purchases.